Found: 107
Select item for more details and to access through your institution.
Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR).
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2963, doi. 10.3390/cancers16172963
- By:
- Publication type:
- Article
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 1, p. 20, doi. 10.4143/crt.2016.057
- By:
- Publication type:
- Article
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0210758
- By:
- Publication type:
- Article
Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201992
- By:
- Publication type:
- Article
Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Hypofractionated stereotactic radiation therapy in skull base meningiomas.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 124, n. 2, p. 283, doi. 10.1007/s11060-015-1838-6
- By:
- Publication type:
- Article
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results.
- Published in:
- Clinical & Experimental Metastasis, 2023, v. 40, n. 2, p. 197, doi. 10.1007/s10585-023-10204-y
- By:
- Publication type:
- Article
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients' selection.
- Published in:
- Clinical & Experimental Metastasis, 2022, v. 39, n. 3, p. 449, doi. 10.1007/s10585-022-10158-7
- By:
- Publication type:
- Article
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study.
- Published in:
- Clinical & Experimental Metastasis, 2022, v. 39, n. 3, p. 443, doi. 10.1007/s10585-022-10157-8
- By:
- Publication type:
- Article
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group.
- Published in:
- Clinical & Experimental Metastasis, 2021, v. 38, n. 6, p. 527, doi. 10.1007/s10585-021-10131-w
- By:
- Publication type:
- Article
Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis.
- Published in:
- Clinical & Experimental Metastasis, 2021, v. 38, n. 6, p. 511, doi. 10.1007/s10585-021-10124-9
- By:
- Publication type:
- Article
Phase II trial of high dose stereotactic body radiation therapy for lymph node oligometastases.
- Published in:
- Clinical & Experimental Metastasis, 2020, v. 37, n. 5, p. 565, doi. 10.1007/s10585-020-10047-x
- By:
- Publication type:
- Article
Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study).
- Published in:
- Current Oncology, 2023, v. 30, n. 7, p. 7073, doi. 10.3390/curroncol30070513
- By:
- Publication type:
- Article
Twenty Years of Advancements in a Radiotherapy Facility: Clinical Protocols, Technology, and Management.
- Published in:
- Current Oncology, 2023, v. 30, n. 7, p. 7031, doi. 10.3390/curroncol30070510
- By:
- Publication type:
- Article
Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk.
- Published in:
- Current Oncology, 2023, v. 30, n. 3, p. 3344, doi. 10.3390/curroncol30030254
- By:
- Publication type:
- Article
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial.
- Published in:
- Current Oncology, 2022, v. 29, n. 12, p. 9349, doi. 10.3390/curroncol29120733
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial.
- Published in:
- Current Oncology, 2022, v. 29, n. 10, p. 7858, doi. 10.3390/curroncol29100621
- By:
- Publication type:
- Article
Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy.
- Published in:
- Current Oncology, 2022, v. 29, n. 7, p. 4893, doi. 10.3390/curroncol29070388
- By:
- Publication type:
- Article
Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
How I faced my prostate cancer: a molecular biologist's perspective.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00229-5
- By:
- Publication type:
- Article
Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 7009, doi. 10.2147/CMAR.S294116
- By:
- Publication type:
- Article
Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 9, p. N.PAG, doi. 10.1007/s11912-020-00948-1
- By:
- Publication type:
- Article
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up.
- Published in:
- Radiation Oncology, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13014-018-1185-9
- By:
- Publication type:
- Article
Correction to: ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long term update on toxicity and survival of a phase II trial of linac‐based stereotactic body radiation therapy for low‐intermediate risk prostate cancer.
- Published in:
- Prostate, 2024, v. 84, n. 4, p. 368, doi. 10.1002/pros.24657
- By:
- Publication type:
- Article
PSMA guided approach for bIoCHEmical relapse after prostatectomy‐ (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga‐PSMA PET/CT within a prospective study.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1201, doi. 10.1002/pros.24579
- By:
- Publication type:
- Article
Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 10, p. 1777, doi. 10.1007/s10147-021-01989-7
- By:
- Publication type:
- Article
Radiomics-based prognosis classification for high-risk prostate cancer treated with radiotherapy.
- Published in:
- Strahlentherapie und Onkologie, 2022, v. 198, n. 8, p. 710, doi. 10.1007/s00066-021-01886-y
- By:
- Publication type:
- Article
Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy.
- Published in:
- Strahlentherapie und Onkologie, 2021, v. 197, n. 5, p. 396, doi. 10.1007/s00066-020-01687-9
- By:
- Publication type:
- Article
Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity.
- Published in:
- Strahlentherapie und Onkologie, 2021, v. 197, n. 2, p. 133, doi. 10.1007/s00066-020-01691-z
- By:
- Publication type:
- Article
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer : Long-term results and factors predictive for outcome and toxicity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rolle von stereotaktischer Körperbestrahlungstherapie in der Behandlung von Lebermetastasen: klinische Befunde und prognostische Faktoren.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rezidivmuster nach stereotaktischer Radiotherapie beim oligometastasierten Prostatakarzinom: eine multiinstitutionelle Analyse.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Vorhersage von Überleben und lokaler Kontrolle nach Radiochemotherapie bei lokal fortgeschrittenen Kopf-Hals-Tumoren mittels computertomographiebasierter Radiomics-Technik.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 12, p. 10495, doi. 10.1007/s00432-023-04964-z
- By:
- Publication type:
- Article
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4411, doi. 10.1007/s00432-022-04352-z
- By:
- Publication type:
- Article
Reply to Letter to the Editor regarding "Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‐)radiotherapy: a systematic review and meta‐analysis".
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1369, doi. 10.1007/s00432-022-04441-z
- By:
- Publication type:
- Article
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1029, doi. 10.1007/s00432-022-03965-8
- By:
- Publication type:
- Article
Response to letter to the editor regarding C Franzese et al. "Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer".
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 4, p. 1003, doi. 10.1007/s00432-021-03801-5
- By:
- Publication type:
- Article
Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 12, p. 3619, doi. 10.1007/s00432-021-03807-z
- By:
- Publication type:
- Article
Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 7, p. 2069, doi. 10.1007/s00432-020-03483-5
- By:
- Publication type:
- Article
Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 5, p. 1307, doi. 10.1007/s00432-021-03518-5
- By:
- Publication type:
- Article
Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 3, p. 927, doi. 10.1007/s00432-020-03389-2
- By:
- Publication type:
- Article
Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 9, p. 2289, doi. 10.1007/s00432-020-03285-9
- By:
- Publication type:
- Article
Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 9, p. 2267, doi. 10.1007/s00432-020-03281-z
- By:
- Publication type:
- Article
Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 5, p. 1227, doi. 10.1007/s00432-020-03148-3
- By:
- Publication type:
- Article
Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 10, p. 2469, doi. 10.1007/s00432-019-03007-w
- By:
- Publication type:
- Article